-
公开(公告)号：EP1864662A1
公开(公告)日：2007-12-12
申请号：EP06730073.1
申请日：2006-03-27
发明人： YOKOYAMA, Toru , AOKI, Taro
IPC分类号： A61K31/47 , A61K31/616 , A61P7/02
CPC分类号： A61K31/22 , A61K31/36 , A61K31/60 , A61K2300/00
摘要： The present invention relates to a therapeutic agent for thrombosis, and more specifically, to a therapeutic agent for thrombosis which is effective for both suppressing blood coagulation and promoting thrombolysis.
The present invention provides a therapeutic agent for thrombosis characterized by containing pitavastatins and aspirin.摘要翻译： 本发明涉及血栓形成治疗剂，更具体地，涉及对抑制血液凝固和促进溶栓治疗有效的血栓形成治疗剂。 本发明提供了一种以含有匹伐他汀和阿司匹林为特征的血栓形成治疗剂。
-
2.发明授权HYPERLIPEMIA THERAPEUTIC AGENT COMPRISING PITAVASTATINS AND EICOSAPENTAENOIC ACID 有权包含双氢青蒿素和二十碳五烯酸的高脂血症治疗剂
公开(公告)号：EP1715865B9
公开(公告)日：2010-12-15
申请号：EP05710692.4
申请日：2005-02-18
发明人： AOKI, Taro , YAMAGUCHI, Junji , SASAKI, Yusuke
IPC分类号： A61K31/47 , A61K31/202 , A61P3/06
CPC分类号： A61K31/47 , A61K31/202 , A61K2300/00
摘要： Abstract The present invention relates to a hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid or an ester derivative thereof as effective ingredients. According to the present invention, a type IIb and type IV hyperlipemia therapeutic agent having an excellent effect of lowering the cholesterol and triglyceride in blood is provided.
摘要翻译： 摘要本发明涉及包含匹伐他汀和二十碳五烯酸或其酯衍生物作为有效成分的高脂血症治疗剂。 根据本发明，提供了具有降低血液中胆固醇和甘油三酯的优异效果的IIb型和IV型高脂血症治疗剂。
-
3.发明授权HYPERLIPEMIA THERAPEUTIC AGENT COMPRISING PITAVASTATINS AND EICOSAPENTAENOIC ACID 有权用于治疗高脂血症WITH PITAVASTATINEN酸和二十碳五烯酸
公开(公告)号：EP1715865B8
公开(公告)日：2010-05-19
申请号：EP05710692.4
申请日：2005-02-18
发明人： AOKI, Taro , YAMAGUCHI, Junji , SASAKI, Yusuke
IPC分类号： A61K31/47 , A61K31/202 , A61P3/06
CPC分类号： A61K31/47 , A61K31/202 , A61K2300/00
摘要： Abstract The present invention relates to a hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid or an ester derivative thereof as effective ingredients. According to the present invention, a type IIb and type IV hyperlipemia therapeutic agent having an excellent effect of lowering the cholesterol and triglyceride in blood is provided.
-
4.发明授权HYPERLIPEMIA THERAPEUTIC AGENT COMPRISING PITAVASTATINS AND EICOSAPENTAENOIC ACID 有权包含双氢青蒿素和二十碳五烯酸的高脂血症治疗剂
公开(公告)号：EP1715865B1
公开(公告)日：2010-03-10
申请号：EP05710692.4
申请日：2005-02-18
发明人： AOKI, Taro , YAMAGUCHI, Junji , SASAKI, Yusuke
IPC分类号： A61K31/47 , A61K31/202 , A61P3/06
CPC分类号： A61K31/47 , A61K31/202 , A61K2300/00
-
5.发明公开TRIGLYCERIDE-LOWERING AGENT AND HYPERINSULINISM-AMELIORATING AGENT 有权MITTEL ZUR TRIGLYZERIDSENKUNG在MITTEL GEGEN HYPERINSULINISMUS
公开(公告)号：EP2000137A2
公开(公告)日：2008-12-10
申请号：EP07736973.4
申请日：2007-03-28
发明人： YOKOYAMA, Toru , AOKI, Taro
IPC分类号： A61K31/47 , A61K31/4422 , A61P3/06 , A61P43/00 , C07D211/90 , C07D215/14
CPC分类号： C07D211/90 , A61K31/4422 , A61K31/47 , C07D215/14 , A61K2300/00
摘要： The present invention is directed to a triglyceride-lowering agent, exhibiting excellent triglyceride-lowering effect and a hyperinsulinemia-ameliorating agent.
The triglyceride-lowering agent and hyperinsulinemia-ameliorating agent are characterized by containing a pitavastatin compound, and amlodipine or a salt thereof.摘要翻译： 本发明涉及显示出优异的甘油三酯降低作用的甘油三酯降低剂和高胰岛素血症改善剂。 甘油三酯降低剂和高胰岛素血症改善剂的特征在于含有匹伐他汀化合物和氨氯地平或其盐。
-
6.发明公开HYPERLIPEMIA THERAPEUTIC AGENT COMPRISING PITAVASTATINS AND EICOSAPENTAENOIC ACID 有权用于治疗高脂血症WITH PITAVASTATINEN酸和二十碳五烯酸
公开(公告)号：EP1715865A2
公开(公告)日：2006-11-02
申请号：EP05710692.4
申请日：2005-02-18
发明人： AOKI, Taro , YAMAGUCHI, Junji , SASAKI, Yusuke
IPC分类号： A61K31/47 , A61K31/202 , A61P3/06
CPC分类号： A61K31/47 , A61K31/202 , A61K2300/00
摘要： Abstract The present invention relates to a hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid or an ester derivative thereof as effective ingredients. According to the present invention, a type IIb and type IV hyperlipemia therapeutic agent having an excellent effect of lowering the cholesterol and triglyceride in blood is provided.
-
7.发明授权TRIGLYCERIDE-LOWERING AGENT AND HYPERINSULINISM-AMELIORATING AGENT 有权手段TRIGLYZERIDSENKUNG和手段，以高胰岛素血症
公开(公告)号：EP2000137B1
公开(公告)日：2015-10-21
申请号：EP07736973.4
申请日：2007-03-28
发明人： YOKOYAMA, Toru , AOKI, Taro
IPC分类号： A61K31/47 , A61K31/4422 , A61P3/06 , A61P43/00 , C07D211/90 , C07D215/14
CPC分类号： C07D211/90 , A61K31/4422 , A61K31/47 , C07D215/14 , A61K2300/00
-
公开(公告)号：EP1785137B1
公开(公告)日：2010-11-24
申请号：EP05777087.7
申请日：2005-08-30
发明人： AOKI, Taro , YAMAZAKI, Hiroyuki , MAEJIMA, Takashi
IPC分类号： A61K31/47 , A61K31/4709 , A61K31/397 , A61P3/06
CPC分类号： A61K31/397 , A61K31/47 , A61K31/4709 , A61K2300/00
摘要： A remedy for hyperlipemia and hypercholesterolemia characterized by containing ezethimibe together with pitavastatine, a pitavastatine salt or a pitavastatine lactone.
-
9.发明公开TRIGLYCERIDE-LOWERING AGENT AND HYPERINSULINISM-AMELIORATING AGENT 有权手段TRIGLYZERIDSENKUNG和手段，以高胰岛素血症
公开(公告)号：EP2000137A9
公开(公告)日：2009-03-18
申请号：EP07736973.4
申请日：2007-03-28
发明人： YOKOYAMA, Toru , AOKI, Taro
IPC分类号： A61K31/47 , A61K31/4422 , A61P3/06 , A61P43/00 , C07D211/90 , C07D215/14
CPC分类号： C07D211/90 , A61K31/4422 , A61K31/47 , C07D215/14 , A61K2300/00
摘要： The present invention is directed to a triglyceride-lowering agent, exhibiting excellent triglyceride-lowering effect and a hyperinsulinemia-ameliorating agent.
The triglyceride-lowering agent and hyperinsulinemia-ameliorating agent are characterized by containing a pitavastatin compound, and amlodipine or a salt thereof.-
公开(公告)号：EP1785137A1
公开(公告)日：2007-05-16
申请号：EP05777087.7
申请日：2005-08-30
发明人： AOKI, Taro , YAMAZAKI, Hiroyuki , MAEJIMA, Takashi
IPC分类号： A61K31/47 , A61K31/397 , A61P3/06
CPC分类号： A61K31/397 , A61K31/47 , A61K31/4709 , A61K2300/00
摘要： Provided is a therapeutic agent for hyperlipemia or hypercholesterolemia, which comprises administering effective doses of ezetimibe and pitavastatin or a salt or lactone derivative thereof.
摘要翻译： 本发明提供高脂血症或高胆固醇血症的治疗剂，其包括施用有效剂量的依泽麦布和匹伐他汀或其盐或内酯衍生物。
-
-
-
-
-
-
-
-
-
搜索结果
23 条记录 (耗时 0.013 秒)
